Contribution of Bone Scintigraphy in Benign Bone Pathology: Illustrative Cases from the Nuclear Medicine Department at the University Hospital of Fez

Authors

  • Assia Seddouki Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco , Centre Hospitalier Universitaire Hassan II image/svg+xml , Sidi Mohamed Ben Abdellah University image/svg+xml
  • Sofia Chkikar Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco , Centre Hospitalier Universitaire Hassan II image/svg+xml , Sidi Mohamed Ben Abdellah University image/svg+xml
  • Esso-Mada Kpekpeou Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco , Centre Hospitalier Universitaire Hassan II image/svg+xml , Sidi Mohamed Ben Abdellah University image/svg+xml
  • Mehdi Goudira Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco , Centre Hospitalier Universitaire Hassan II image/svg+xml , Sidi Mohamed Ben Abdellah University image/svg+xml
  • Nadia Ismaili Alaoui Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco , Centre Hospitalier Universitaire Hassan II image/svg+xml , Sidi Mohamed Ben Abdellah University image/svg+xml

DOI:

https://doi.org/10.59667/sjoranm.v7i1.12

Keywords:

bone scintigraphy, benign bone pathology, SPECT/CT, lesion localization, bone metabolism, case series

Abstract

Bone scintigraphy is a sensitive whole-body technique for assessing osteoblastic activity and can support the evaluation of infectious, traumatic, metabolic, developmental, and benign neoplastic bone disorders. This educational review summarizes the principles and practical conduct of planar bone scintigraphy and hybrid SPECT/CT and presents 14 illustrative cases from the Nuclear Medicine Department of Hassan II University Hospital Center in Fez. The cases demonstrate the contribution of multiphase imaging and SPECT/CT to lesion localization and characterization in septic pseudarthrosis, osteochondritis, brown tumors, osteoblastoma, neurogenic para-osteoarthropathy, Langerhans cell histiocytosis, osteogenesis imperfecta, focal osteoarticular inflammation, polyostotic fibrous dysplasia, Paget disease, femoral-head osteonecrosis, osteoid osteoma, active condylar hyperplasia, and renal osteodystrophy. The examples are illustrative and do not define universal image-quality or equipment standards. Interpretation must integrate the clinical question, laboratory findings, anatomic imaging, and, when indicated, histopathology.

Author Biographies

  • Assia Seddouki, Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco, Centre Hospitalier Universitaire Hassan II, Sidi Mohamed Ben Abdellah University

    Nuclear medicine physician at the Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco.

  • Sofia Chkikar, Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco, Centre Hospitalier Universitaire Hassan II, Sidi Mohamed Ben Abdellah University

    Nuclear medicine physician at the Department of Nuclear Medicine, Centre Hospitalier Universitaire Hassan II, Fez, Morocco.

  • Esso-Mada Kpekpeou, Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco, Centre Hospitalier Universitaire Hassan II, Sidi Mohamed Ben Abdellah University

    Physician of Nuclear Medicine, Centre Hospitalier Universitaire Hassan II, Fez, Morocco

  • Mehdi Goudira, Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco, Centre Hospitalier Universitaire Hassan II, Sidi Mohamed Ben Abdellah University

    Nuclear medicine physician at the Department of Nuclear Medicine, Centre Hospitalier Universitaire Hassan II, Fez, Morocco.

  • Nadia Ismaili Alaoui, Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco, Centre Hospitalier Universitaire Hassan II, Sidi Mohamed Ben Abdellah University

    Professor Nadia Ismaili Alaoui is Head of the Department of Nuclear Medicine at Centre Hospitalier Universitaire Hassan II in Fez, Morocco.

References

1. Dumont M, Côté C. La scintigraphie osseuse en trois phases pancorporelles. Médecine Nucléaire. 2012;36(11):678–686. https://doi.org/10.1016/j.mednuc.2012.09.002 DOI: https://doi.org/10.1016/j.mednuc.2012.09.002

2. Granier P, Mourad M. Exploration des polyalgies par la scintigraphie osseuse planaire couplée à la TEMP-TDM. Médecine Nucléaire. 2011;35(2):71–82. https://doi.org/10.1016/j.mednuc.2010.12.003 DOI: https://doi.org/10.1016/j.mednuc.2010.12.003

3. Parisi MT, Otjen JP, Stanescu AL, Shulkin BL. Radionuclide imaging of infection and inflammation in children: a review. Seminars in Nuclear Medicine. 2018;48(2):148–165. https://doi.org/10.1053/j.semnuclmed.2017.11.002 DOI: https://doi.org/10.1053/j.semnuclmed.2017.11.002

4. Paycha F, Girma A, Granier P, et al. Guide pour la rédaction de protocole pour la scintigraphie osseuse. Médecine Nucléaire. 2012;36(11):687–697. https://doi.org/10.1016/j.mednuc.2012.09.003 DOI: https://doi.org/10.1016/j.mednuc.2012.09.003

5. Van den Wyngaert T, Strobel K, Kampen WU, et al. The EANM practice guidelines for bone scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging. 2016;43:1723–1738. https://doi.org/10.1007/s00259-016-3415-4 DOI: https://doi.org/10.1007/s00259-016-3415-4

6. Agence nationale de sécurité du médicament et des produits de santé. OSTEOCIS 3 mg, trousse pour préparation radiopharmaceutique: Résumé des caractéristiques du produit. Updated September 8, 2022. https://base-donnees-publique.medicaments.gouv.fr/medicament/63521034/extrait

SJORANM article cover, Vol. 7 No. 1 (2024). Holographic symbolic illustration for article 23.

Downloads

Published

2026-09-29 — Updated on 2024-04-14

Data Availability Statement

The clinical data supporting this article are not publicly available because they contain information that could compromise patient privacy. Further information may be obtained from the corresponding author upon reasonable request, subject to applicable ethical and institutional requirements.

Issue

Vol. 7 No. 1 (2024)

Section

Case reports

License

Copyright (c) 2024 Assia Seddouki, Dr Sofia Chkikar, Essomada KPEKPEOU, Dr Mehdi Goudira, Pr Nadia Imaili Alaoui

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This license requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, even for commercial purposes.

How to Cite

Seddouki, A., Chkikar, S., Kpekpeou, E.-M., Goudira, M., & Ismaili Alaoui, N. (2024). Contribution of Bone Scintigraphy in Benign Bone Pathology: Illustrative Cases from the Nuclear Medicine Department at the University Hospital of Fez. Swiss Journal of Radiology and Nuclear Medicine, 7(1), 1-18. https://doi.org/10.59667/sjoranm.v7i1.12

Share

Similar Articles

1-10 of 83

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)